SANA Sana Biotechnology, Inc. Common Stock

Last close: 2.37
504-day return: -35.25%
Median $/day: $9.7M
Relationships shown: 13

together opposite · bar = ρ at each lag, −10 … 0 … +10 days · holdout ρ · click a card for the full picture

SANA vs ABSI

Both indexed to 100 at 2026-05-11.

SANA ABSI · range 64–209 · 2026-05-11 → 2026-11-06

Moves with SANA

Same day, ranked by what's left after the market and sector factors are removed ("beyond mkt").

ABSI Absci Corporation Common Stock

ρ +0.54beyond mkt +0.25holdout +0.53stable 100%robust

CRSP CRISPR Therapeutics AG Common Shares

ρ +0.56beyond mkt +0.23holdout +0.62stable 100%robust

FATE Fate Therapeutics, Inc. Common Stock

ρ +0.50beyond mkt +0.21holdout +0.47stable 100%robust

EDIT Editas Medicine, Inc. Common Stock

ρ +0.54beyond mkt +0.19holdout +0.59stable 100%robust

BEAM Beam Therapeutics Inc. Common Stock

ρ +0.53beyond mkt +0.16holdout +0.55stable 100%robust

NTLA Intellia Therapeutics, Inc. Common Stock

ρ +0.53beyond mkt +0.16holdout +0.55stable 100%robust

Moves against SANA

BTAL AGF U.S. Market Neutral Anti-Beta Fund

ρ -0.37beyond mkt -0.03holdout -0.39stable 100%robust

VXX iPath Series B S&P 500 VIX Short-Term Futures ETN

ρ -0.34beyond mkt -0.02holdout -0.33stable 75%robust

Weekly, not daily

No day-to-day relationship, but 5- or 10-day returns move together.

CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock

horizon 10dρ +0.51holdout +0.53stable 88%robust

CRDL Cardiol Therapeutics Inc. Class A Common Shares

horizon 10dρ +0.42holdout +0.35stable 62%moderate

ANIX Anixa Biosciences, Inc. Common Stock

horizon 10dρ +0.39holdout +0.51stable 75%robust

CPNG Coupang, Inc.

horizon 5dρ +0.33holdout +0.46stable 62%moderate

SABS SAB Biotherapeutics, Inc. Common Stock

horizon 5dρ +0.30holdout +0.55stable 62%moderate

Changed this quarter

Biggest shifts in same-day correlation over the last 63 trading days versus the year before.

FRNM Freenome, Inc. Common stock

Δ +0.54recent +0.49prior -0.05beyond mkt -0.01

CTNM Contineum Therapeutics, Inc. Class A Common Stock

Δ +0.50recent +0.59prior +0.09beyond mkt -0.09

IMRX Immuneering Corporation Class A Common Stock

Δ +0.49recent +0.67prior +0.19beyond mkt -0.09

SABS SAB Biotherapeutics, Inc. Common Stock

Δ +0.47recent +0.67prior +0.19beyond mkt +0.03

BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock

Δ +0.47recent +0.58prior +0.11beyond mkt +0.01

CRVS Corvus Pharmaceuticals, Inc. Common Stock

Δ +0.46recent +0.77prior +0.31beyond mkt -0.00